Western blot analysis of Lane 1: Paclitaxel treated Jurkat cells, Lane 2: antigen-specific peptide treated Jurkat cells with RAF1 (phospho Y341) polyclonal antibody (Cat# PAB29265) at 1:500-1:1000 dilution.
Immunohistochemical staining (Formalin-fixed paraffin-embedded sections) of human pancreas tissue with RAF1 (phospho Y341) polyclonal antibody (Cat# PAB29265) without blocking peptide (A) or preincubated with blocking peptide (B) under 1:50-1:100 dilution.
This gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell physiology and play an important role in the control of gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration. Mutations in this gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. [provided by RefSeq
Oncogene RAF1,raf proto-oncogene serine/threonine protein kinase